Temozolomide Accord

Temozolomide Accord is an oral chemotherapy medication used in cancer treatment. It belongs to the class of alkylating agents and is prescribed under medical supervision. This product is manufactured by Accord Healthcare S.L.U. and is available in the EU.

Temozolomide Accord is primarily used to treat certain types of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma. It may also be prescribed for other cancers as determined by a healthcare professional. This medication works by slowing or stopping the growth of cancer cells. Patients often ask, 'what is temozolomide used for' to understand its role in treatment.

Temozolomide Accord may cause side effects such as nausea, vomiting, or fatigue. Some patients experience a temporary decrease in blood cell counts, which can increase infection risk. Hair loss is another possible effect. These effects vary by individual and should be monitored by a healthcare provider.

Temozolomide Accord should be handled with care, especially by those who are pregnant or breastfeeding. It is important to follow medical guidance regarding its use and to report any unusual symptoms promptly. Patients should avoid direct contact with broken tablets and wash hands thoroughly after handling.

Temozolomide Accord may interact with other medications, including certain chemotherapy drugs, anticoagulants, and vaccines. Alcohol and herbal supplements should be used cautiously. Patients should inform their healthcare provider about all medications and supplements they are taking to avoid potential interactions.